Related Experiment Videos
Lymphocytic and erythrocytic k+, Na+, Ca++, Mg++ content in patients with congestive heart failure
Insights
Electrolyte levels in lymphocytes and red blood cells change in congestive heart failure patients, worsening with disease duration. These electrolyte shifts, particularly in lymphocytes and erythrocytes, offer insights into heart failure prognosis and treatment.
Area of Science:
- Cardiology
- Biochemistry
- Internal Medicine
Background:
- Congestive heart failure (CHF) is associated with electrolyte imbalances.
- Serum electrolyte levels may not accurately represent overall body electrolyte metabolism.
- Changes in lymphocytic and erythrocytic electrolyte content in CHF are not well-documented.
Purpose of the Study:
- To investigate changes in lymphocytic and erythrocytic potassium (K+), sodium (Na+), calcium (Ca++), and magnesium (Mg++) content in CHF patients.
- To correlate these electrolyte changes with disease duration, etiology, and treatment response.
- To assess the utility of lymphocytic and erythrocytic electrolytes in predicting clinical treatment and prognosis of CHF.
Main Methods:
- Analysis of lymphocytic and erythrocytic K+, Na+, Ca++, and Mg++ content in patients with CHF.
- Comparison of electrolyte levels based on disease duration, etiology, and New York Heart Association (NYHA) functional classification (Class III vs. Class IV).
- Evaluation of electrolyte changes before and after CHF treatment.
Main Results:
- Significant alterations in lymphocytic and erythrocytic electrolytes were observed in CHF patients.
- Electrolyte changes intensified with longer disease duration, irrespective of heart disease etiology.
- Partial improvement in electrolyte levels was noted after CHF treatment.
- No significant difference in electrolyte content was found between NYHA Class III and IV patients.
- Electrolyte metabolic changes occur in myocardial, skeletal muscle, and red blood cells, but serum levels are not precise indicators.
Conclusions:
- Lymphocytic and erythrocytic electrolyte content is altered in CHF and correlates with disease progression.
- These intracellular electrolyte changes are partially reversible with treatment.
- Lymphocytic and erythrocytic electrolyte analysis may provide valuable reference for clinical management and prognosis of CHF, complementing serum electrolyte measurements.
Abstract:
The content of lymphocytic and erythrocytic K+, Na+, Ca++, Mg++ changed in patients with congestive heart failure, related to clinical treatment and prognosis. The longer the course of disease, the more significant the changes, with no relation to the etiology of heart disease. The changes were partially improved after treatment of the heart failure. The content of electrolytes is not significantly different in patients in NYHA Class III, compared to those in NYHA Class IV. The metabolic changes of electrolytes occur on the myocardial cells, skeletal muscle cells and peripheral erythrocytes in patients with congestive heart failure. However, serum electrolyte content does not reflect precisely overall electrolyte metabolism in the body. Whether similar changes of electrolyte content occur in the peripheral lymphocytes is rarely reported. We studied the lymphocytic and erythrocytic electrolyte content in patients with congestive heart failure, to provide some reference in the clinical treatment and prognosis of congestive heart failure.